การนำทาง
แนวโน้มตลาด ตัวคัดกรองหุ้น ปฏิทินการจ่ายเงินปันผล ปฏิทินกิจกรรม อันดับหุ้น ข่าวการตลาด
ทดลองฟรี

Rubius Therapeutics

NASDAQ RUBY
- - -%
Today share price
สหรัฐอเมริกา
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 23 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

5.15M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-8.62M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.57
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
90.31M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-

Upcoming events Rubius Therapeutics

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Rubius Therapeutics

Stock analysis Rubius Therapeutics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-0.02 28.60
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
0.34 4.18
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
0.06 11.39
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.09 0.25
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-1,525.76 10.75

Price change Rubius Therapeutics per year

4.24$ 32.97$
Min Max

Summary analysis Rubius Therapeutics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Rubius Therapeutics

Revenue and net income Rubius Therapeutics

All parameters

Stock news Rubius Therapeutics

All news
13 กันยายน 2022 в 14:35

Rubius Therapeutics to Restructure, Lay Off 75% of Work Force

13 กันยายน 2022 в 14:35

Rubius Therapeutics to Restructure, Lay Off 75% of Work Force

11 เมษายน 2022 в 21:31

Rubius Therapeutics Down 24%

11 เมษายน 2022 в 21:31

Rubius Therapeutics Down 24%

About company Rubius Therapeutics

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of cancer; and RTX-aAPC to treat solid and hematological cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Address:
399 Binney Street, Cambridge, MA, United States, 02139
Company name: Rubius Therapeutics
Issuer ticker: RUBY
ISIN: US78116T1034
Country: สหรัฐอเมริกา
Exchange: NASDAQ
Currency: $
IPO date: 2018-07-18
Sector: Healthcare
Industry: Biotechnology
Site: https://www.rubiustx.com

On which stock exchange are Rubius Therapeutics (RUBY) stocks traded?

Rubius Therapeutics (RUBY) stocks are traded on NASDAQ.

What is the ticker of Rubius Therapeutics stocks (RUBY)?

The stock ticker of Rubius Therapeutics’s stocks or in other words, the code is RUBY. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Rubius Therapeutics (RUBY) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Rubius Therapeutics (RUBY) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Rubius Therapeutics (RUBY) stocks traded?

Rubius Therapeutics (RUBY) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Rubius Therapeutics (RUBY) stocks today?

The current price of Rubius Therapeutics stocks on 23.05.2024 is dollars. per share.

What is the dynamics of Rubius Therapeutics (RUBY) stocks from the beginning of the year?

Rubius Therapeutics (RUBY) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did Rubius Therapeutics (RUBY) stocks increase in мае 2024?

This month Rubius Therapeutics (RUBY) quotes have increased by 0% to dollars. per share.

How much are Rubius Therapeutics (RUBY) stocks worth?

Today, on October, 23.05.2024 Rubius Therapeutics’s (RUBY) stocks cost dollars..

What is the market capitalization of Rubius Therapeutics (RUBY)?

Capitalization is the market value of Rubius Therapeutics (RUBY) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 23.05.2024, the market capitalization of Rubius Therapeutics (RUBY) is estimated at about 5147411 dollars.